# Equibal Inc – FDA Inspection, May 30, 2024

Source: https://www.keypedia.com/records/fda_inspections/equibal-inc/4cd3e046-3b45-41de-89cf-f7b7cd40c43c
Source feed: FDA_Inspections

> FDA inspection 1239888 of Equibal Inc, May 30, 2024. Classification: Voluntary Action Indicated (VAI). 11 citations under 21 CFR part 211. 1 other FDA inspection on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1239888
- Company Name: Equibal Inc
- Inspection Date: 2024-05-30
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 11

## Related Documents

- [FDA Inspection 972172 - 2016-05-27](https://www.keypedia.com/records/fda_inspections/equibal-inc/7732a06a-4e15-440f-82be-1bf972919bbb)

## Related Officers

- [Company Rep](https://www.keypedia.com/people/ifechimere-i-okafor/c48399bf-47d9-4562-9130-1e6731eca07d)
- [Paige R. McCoy](https://www.keypedia.com/people/paige-r-mccoy/d871e1a3-ec99-4c8b-a12f-477d7719f09a)
- [FDA Associated Person](https://www.keypedia.com/people/pushpa-s-jayasekara/cfd7d22f-b4c2-4002-ae18-b5435815d27d)

Company: https://www.keypedia.com/companies/equibal-inc/d13eee64-2a7b-4828-946c-a243b1fe074d

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c